会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明授权
    • Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
    • 牛瘦蛋白,其编码的核酸序列及其用途
    • US06297027B1
    • 2001-10-02
    • US08688908
    • 1996-07-31
    • Michael E. Spurlock
    • Michael E. Spurlock
    • C07K14435
    • C07K14/5759
    • A bovine adipocyte-specific polypeptide, termed leptin, is expressed in the fat tissue of cattle. Expression may be altered in over fat cattle, or expression may be in the form of a protein of lesser biological activity relative to that of leaner cattle. The bovine adipocyte polypeptide, DNA and RNA molecules coding therefor, methods for its preparation, and antibodies specific for the polypeptide are disclosed. Methods for determining the susceptibility of cattle to fat deposition are based on measuring the levels of the bovine adipocyte polypeptide in a biological fluid or tissue extract or by measuring mRNA encoding the bovine adipocyte polypeptide in cells of the subject. Methods of evaluating an agent related to the deposition of fat in cattle comprise contacting the agent with an adipocyte in vitro and measuring the amount of the bovine adipocyte polypeptide or mRNA that is produced by the adipocyte. Methods of limiting fat deposition include administering leptin or leptin DNA, and methods of altering intake include administering leptin, leptin DNA, or an antibody directed against leptin.
    • 称为瘦素的牛脂肪细胞特异性多肽在牛的脂肪组织中表达。 表达可能在过度肥胖的牛中改变,或者表达可以是相对于瘦牛的生物活性较小的蛋白质的形式。 公开了牛脂肪细胞多肽,其编码的DNA和RNA分子,其制备方法和针对该多肽的抗体。 用于确定牛对脂肪沉积的易感性的方法是基于测量生物流体或组织提取物中牛脂肪细胞多肽的水平,或通过测量受试者细胞中编码牛脂肪细胞多肽的mRNA。 评估与牛中脂肪沉积有关的试剂的方法包括在体外使试剂与脂肪细胞接触并测量由脂肪细胞产生的牛脂肪细胞多肽或mRNA的量。 限制脂肪沉积的方法包括施用瘦蛋白或瘦蛋白DNA,以及改变摄入的方法包括施用瘦蛋白,瘦素DNA或针对瘦蛋白的抗体。
    • 53. 发明授权
    • Compositions for the treatment of body weight disorders including obesity
    • 用于治疗体重障碍(包括肥胖症)的组合物
    • US6057109A
    • 2000-05-02
    • US210681
    • 1998-12-14
    • Louis Anthony Tartaglia
    • Louis Anthony Tartaglia
    • A61K38/00C07K14/47C07K14/575C12N15/12C12Q1/68
    • C07K14/5759C07K14/4702A01K2217/05A61K38/00
    • The present invention relates to methods and compositions for the treatment of body weight disorders, including, but not limited to, obesity. Specifically, the present invention identifies and describes genes which are differentially expressed in body weight disorder states, relative to their expression in normal, or non-body weight disorder states, and/or in response to manipulations relevant to appetite and/or weight regulation. Further, the present invention identifies and describes genes via the ability of their gene products to interact with gene products involved in body weight disorders and/or appetite and/or body weight regulation. Still further, the present invention provides methods for the identification and therapeutic use of compounds as treatments of body weight disorders. Additionally, the present invention describes methods for the diagnostic evaluation and prognosis of various body weight disorders, and for the identification of subjects exhibiting a predisposition to such conditions.
    • 本发明涉及用于治疗体重障碍的方法和组合物,包括但不限于肥胖症。 具体地,本发明鉴定并描述了相对于在正常或非体重紊乱状态下表达和/或响应于与食欲和/或体重调节相关的操作而在体重紊乱状态下差异表达的基因。 此外,本发明通过其基因产物与涉及体重紊乱和/或食欲和/或体重调节的基因产物相互作用的能力来鉴定和描述基因。 此外,本发明提供了用于鉴定和治疗使用化合物作为体重紊乱治疗的方法。 此外,本发明描述了各种体重障碍的诊断评价和预后的方法,以及用于鉴定表现出这种病症倾向的受试者。